SANOFICONR4,180.00

Sanofi Consumer Healthcare India Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersPGHLSANOFISENORESINNOVACAPMOREPENLABIOLCPFDCASTRAZENMcap ₹9,614 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY25
31/12/2024
FY26
31/12/2025
Last 12M
30/06/2026
Revenue from Operations724.5878.4949.8
Other Income13.018.419.5
Total Income737.5896.8969.3
Expenses
+ Cost of Materials Consumed127.4160.7174.1
+ Purchases of Stock-in-Trade42.170.266.2
+ Changes in Inventories16.6-0.82.3
+ Employee Benefit Expense102.7128.8131.6
+ Finance Costs3.92.02.0
+ Depreciation & Amortisation4.511.713.2
+ Other Expenses165.1210.5222.7
Total Expenses462.3583.1612.1
EBITDA270.6309.0352.9
EBIT266.1297.3339.7
Profit
PBT before Exceptional Items275.2313.7357.2
+ Exceptional Items-28.46.60.0
Pretax Income246.8320.3357.2
+ Current Tax69.682.094.1
+ Deferred Tax-3.8-1.8-2.9
Tax Expense65.880.291.2
Net Income181.0240.1266.0
+ Net Income — Continuing Ops181.0240.1266.0
+ Other Comprehensive Income-1.4-1.4-1.4
Total Comprehensive Income179.6238.7264.6
Per Share
Basic EPS78.59104.27115.49
Diluted EPS0.00104.27115.49
Other Comprehensive Income — detail
+ Other Comprehensive Income-1.4
+ Items NOT to be Reclassified to P&L-1.9-1.9
+ Tax on Items NOT to be Reclassified-0.5
+ Tax on Items NOT to be Reclassified — alt tag-0.5
Per Share — as-filed variants
Basic EPS — Continuing Operations78.59104.27115.49
Diluted EPS — Continuing Operations0.00104.27115.49
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit538.4648.3707.2
Gross Margin %74.3173.8074.46
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)275.2313.7357.2
− Exceptional Items (reconciliation)-28.46.60.0
Net Income Adj (tax-effected)201.8235.2266.0
EPS Adj87.63102.12115.49
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.00
Paid Up Equity Capital23.023.023.0
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.